The risk of developing cardiovascular disease in bipolar disorder. Clinical and social factors
- Authors: Mosolov S.N.1,2, Fedorova E.Y.1
-
Affiliations:
- The Serbsky State Scientific Center for Social and Forensic Psychiatry
- Russian Medical Academy of Continuous Professional Education
- Issue: Vol 93, No 12 (2021)
- Pages: 1556-1561
- Section: Reviews
- URL: https://journals.rcsi.science/0040-3660/article/view/96511
- DOI: https://doi.org/10.26442/00403660.2021.12.201175
- ID: 96511
Cite item
Full Text
Abstract
Bipolar disorder (BD) is one of the most common mental disorders in the world with high mortality and a hard economic burden. Although suicide is the leading cause of death in BD, cardiovascular disease (CVD) also contributes significantly to this rate, the risk of which is seriously underestimated in BD. A sample assessment was made of current studies focusing on the link between BD and CVD. The search was carried out in the PubMed and eLIBRARY databases for the following keywords: bipolar disorder, psychopharmacology, cardiovascular disease, metabolic syndrome. The association between BD and vascular disease is large. The analysis of adjusted mortality estimates in patients with bipolar disorder showed a significant contribution of CVD. A detailed study of the mutual influence of bipolar disorder BD and CVD is difficult due to the earlier manifestation of BD in comparison with CVD. Most of the studies have focused on cardiovascular risk factors (CVRFs), which are more common in BD than in the general population. Metabolic syndrome (MS) plays a significant role among CVRFs. The reasons for the development of MS in patients with BD are currently not known for sure, however, the instigated factors are certainly a disturbance of the diet, decreased physical activity, pharmacological therapy, and the lack of early preventive and medical care. Patients with hyperuricemia had a higher risk of developing MS. Lifestyle correction and a reduction of CVFRs, as well as the rational use of certain cardiac drugs can improve the better prognosis of the disease and reduce mortality in patients with BD. The predisposition of patients with BD to CVD is undeniable. It is necessary to consider the high frequency of CVRFs in people with BD, and promptly recommend appropriate treatment and special rehabilitation programs for the prevention of CVD complications, considering the change in affective phases and the applied mood-stabilizing drugs.
Full Text
##article.viewOnOriginalSite##About the authors
Sergey N. Mosolov
The Serbsky State Scientific Center for Social and Forensic Psychiatry; Russian Medical Academy of Continuous Professional Education
Author for correspondence.
Email: profmosolov@mail.ru
ORCID iD: 0000-0002-5749-3964
д-р мед. наук, проф., рук. отд. терапии психических заболеваний Московского научно-исследовательского института психиатрии, зав. каф. психиатрии, председатель правления московского отд-ния Российского общества психиатров, президент Российского общества биологической психиатрии
Russian Federation, Moscow; MoscowElizaveta Yu. Fedorova
The Serbsky State Scientific Center for Social and Forensic Psychiatry
Email: profmosolov@mail.ru
ORCID iD: 0000-0002-4759-5043
мл. науч. сотр. отд. терапии психических расстройств Московского научно-исследовательского института психиатрии
Russian Federation, MoscowReferences
- Мосолов С.Н. Биполярное аффективное расстройство: диагностика и лечение. М.: МЕДпресс-информ, 2008 [Mosolov SN. Bipoliarnoe affektivnoe rasstroistvo: diagnostika i lechenie. Moscow: MEDpress-inform, 2008 (in Russian)].
- Мосолов С.Н., Ушкалова А.В., Костюкова Е.Г., и др. Диагностика биполярного аффективного расстройства II типа среди пациентов с текущим диагнозом рекуррентного депрессивного расстройства. Современная терапия психических расстройств. 2014;2:2-12 [Mosolov SN, Ushkalova AV, Kostyukova EG, et al. Diagnostics of Bipolar II Disorder among patients with the current diagnosis of Recurrent Depressive Disorder. Current Therapy of Mental Disorders. 2014;2:2-12 (in Russian)].
- Мосолов С.Н., Шафаренко А.А., Ушкалова А.В., и др. Формализованная диагностика биполярного аффективного расстройства у больных с приступообразной шизофренией и шизоаффективным расстройством. Современная терапия психических расстройств. 2014;3:2-7 [Mosolov SN, Shafarenko AA, Ushkalova AV, et al. Misdiagnosis of Bipolar I Disorder among patients with the diagnoses of paranoid schizophrenia and schizoaffective disorder in Russian Federation. Current Therapy of Mental Disorders. 2014;3:2-7 (in Russian)].
- Angst J, Azorin JM, Bowden CL, et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry. 2011;68:791-8. doi: 10.1001/archgenpsychiatry.2011.87
- Мосолов С.Н., Ушкалова А.В., Костюкова Е.Г., и др. Валидизация российской версии опросника HCL-32 для выявления пациентов с биполярным аффективным расстройством 2-го типа среди больных, наблюдающихся с диагнозом рекуррентного депрессивного расстройства. Социальная и клиническая психиатрия. 2015;25(1):21-30 [Mosolov SN, Ushkalova AV, Kostyukova EG, et al. Validation of the HCL-32 Russian Version for detection of Bipolar II Disorder patients among those with diagnosis of Recurrent Depressive Disorder. Social and Clinical Psychiatry. 2015;25(1):21-30 (in Russian)].
- Mosolov SN, Ushkalova AV, Kostiukova EG, et al. Validation of the Russian version of the hypomania checklist (HCL-32) for the detection of bipolar ii disorder in patients with a current diagnosis of recurrent depression. Journal of Affective Disorders. 2014;155(1):90-5. doi: 10.1016/j.jad.2013.10.029
- Mosolov SN, Yaltonskaya PA, Senko OV, et al. Validation of the Russian version of the hypomania checklist (HCL-33) for the detection of bipolar disorder in patients with a current diagnosis of recurrent depression. Journal of Affective Disorders Reports. 2021;4:1-7(100086). doi: 10.1016/j.jadr.2021.100086
- Ушкалова А.В., Костюкова Е.Г., Мосолов С.Н. Современная терапия депрессивной фазы при биполярном аффективном расстройстве (обзор). Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуск. 2012;112(11):67-76 [Ushkalova AV, Kostiukova EG, Mosolov SN. Modern treatment of a depressive phase (review). S.S. Korsakov Journal of Neurology and Psychiatry. Special issue. 2012;112(11):67-76 (in Russian)].
- Сердечно-сосудистые заболевания. Всемирная Организация Здравоохранения. Режим доступа: https://www.who.int/ru/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Ссылка активна на 03.08.2020 [Cardiovascular diseases. World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed: 03.08.2020 (in Russian)].
- Osby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiat. 2001;58:844-50. doi: 10.1001/archpsyc.58.9.844
- Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry. 2011;23:40-7.
- Laursen TM, Mortensen PB, MacCabe JH, et al. Cardiovascular drug use and mortality in patients with schizophrenia or bipolar disorder: A Danish population-based study. Psychol Med. 2014;44:1625-37. doi: 10.1017/S003329171300216X
- Osby U, Westman J, Hallgren J, et al. Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987-2010. Eur J Public Health. 2016;26:867-71. doi: 10.1093/eurpub/ckv245
- Goldstein BI, Schaffer A, Wang S, et al. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort. J Clin Psychiatry. 2015;76:163-9. doi: 10.4088/JCP.14m09300
- Goldstein BI, Baune BT, Bond DJ, et al. Call to Action Regarding the Vascular-Bipolar Link: A Report from the Vascular Task Force of the International Society for Bipolar Disorders. Bipolar Disord. 2020;22(5):440-60. doi: 10.1111/bdi.12921
- Zhao Z, Okusaga OO, Quevedo J, et al. The potential association between obesity and bipolar disorder: A meta-analysis. J Affect Disord. 2016;202:120-3. doi: 10.1016/j.jad.2016.05.059
- Ayerbe L, Forgnone I, Addo J, et al. Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia; a systematic review and meta-analysis. J Affect Disord. 2018;225:665-70. doi: 10.1016/j.jad.2017.09.002
- Vancampfort D, Correll CU, Galling B, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15:166-74. doi: 10.1002/wps.20309
- Heffner JL, Strawn JR, DelBello MP, et al. The co-occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disorders. 2011;13:439-53. doi: 10.1111/j.1399-5618.2011.00943.x
- Goldstein BI, Fagiolini A, Houck P, et al. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disorders. 2009;11:657-62. doi: 10.1111/j.1399-5618.2009.00735.x
- Malhotra N, Kulhara P, Chakrabarti S, et al. Lifestyle related factors & impact of metabolic syndrome on quality of life, level of functioning & self-esteem in patients with bipolar disorder & schizophrenia. Indian J Med Res. 2016;143:434-42. doi: 10.4103/0971-5916.184284
- McElroy SL, Frye MA, Suppes T, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002;63:207-13. doi: 10.4088/jcp.v63n0306
- Peters AT, Shesler LW, Sylvia L, et al. Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression. Aust N Z J Psychiatry. 2016;50:667-77. doi: 10.1177/0004867415616694
- Goldstein BI, Blanco C, He JP, et al. Correlates of Overweight and Obesity Among Adolescents With Bipolar Disorder in the National Comorbidity Survey-Adolescent Supplement (NCS-A). JAACAP. 2016;55:1020-6. doi: 10.1016/j.jaac.2016.08.010
- Mosolov S, Ushkalova A, Kostukova E, et al. Bipolar II disorder in patients with a current diagnosis of recurrent depression. Bipolar Disorders. 2014;16(4):389-99. doi: 10.1111/bdi.12192
- Petri E, Bacci O, Barbuti M, et al. Obesity in patients with major depression is related to bipolarity and mixed features: evidence from the BRIDGE-II-MIX study. Bipolar Disorders. 2017;378(12):1561-8. doi: 10.1111/bdi.12519
- Конорева А.Е., Мосолов С.Н. Когнитивные нарушения при биполярном аффективном расстройстве. Современная терапия психических расстройств. 2017;4:11-8 [Konoreva AE, Mosolov SN. Cognitive Impairment in Bipolar Affective Disorder. Modern Therapy for Mental Disorders. 2017;4:11-8 (in Russian)]. doi: 10.21265/PSYPH.2017.43.8416
- Mora E, Portella MJ, Martinez-Alonso M, et al. The Impact of Obesity on Cognitive Functioning in Euthymic Bipolar Patients: A Cross-Sectional and Longitudinal Study. J Clin Psychiatry. 2017;78:924-32. doi: 10.4088/JCP.16m10968
- Bond DJ, Torres IJ, Lee SS, et al. Lower cognitive functioning as a predictor of weight gain in bipolar disorder: a 12-month study. Acta Psych Scand. 2017;135:239-49. doi: 10.1111/acps.12674
- Depp CA, Bowie CR, Mausbach BT, et al. Current smoking is associated with worse cognitive and adaptive functioning in serious mental illness. Acta Psych Scand 2015;131:333-41. doi: 10.1111/acps.12380
- Новичкова Н. И., Каллистов Д.Ю., Романова Е.А. Нарушения сна и хронический стресс как факторы риска сердечно-сосудистых заболеваний. Российский кардиологический журнал. 2015;6(122):20-4 [Novichkova NI, Kallistov DY, Romanova EA. Sleep disorders and chronic stress as cardiovascular risk factors. Russian Journal of Cardiology. 2015;6(122):20-4 (in Russian)]. doi: 10.15829/1560-4071-2015-6-20-24
- Harvey AG, Schmidt DA, Scarna A, et al. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry. 2005;162:50-7. doi: 10.1176/appi.ajp.162.1.50
- Cooper CB, Neufeld EV, Dolezal BA, et al. Sleep deprivation and obesity in adults: a brief narrative review. BMJ Open Sport & Exercise Medicine. 2018;4:e000392. doi: 10.1136/bmjsem-2018-000392
- Sylvia LG, Chang WC, Kamali M, et al. Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial. J Affect Disord. 2018;225:563-8. doi: 10.1016/j.jad.2017.08.056
- Melo MC, Daher Ede F, Albuquerque SG, et al. Exercise in bipolar patients: A systematic review. J Affect Disord. 2016;198:32-8. doi: 10.1016/j.jad.2016.03.004
- Vancampfort D, Wyckaert S, Sienaert P, et al. The functional exercise capacity in patients with bipolar disorder versus healthy controls: A pilot study. Psychiatry Res. 2015;229:194-9. doi: 10.1016/j.psychres.2015.07.040
- Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ. 2001;322:763-7. doi: 10.1136/bmj.322.7289.763
- Ng F, Dodd S, Berk M. The effects of physical activity in the acute treatment of bipolar disorder: a pilot study. J Affect Dis. 2007;101:259-62. doi: 10.1016/j.jad.2006.11.014
- Daumit GL, Dickerson FB, Wang NY, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013;368:1594-602. doi: 10.1056/NEJMoa1214530
- Abosi O, Lopes S, Schmitz S, et al. Cardiometabolic effects of psychotropic medications. Horm Mol Biol Clin Investig. 2018;36(1). doi: 10.1515/hmbci-2017-0065
- Мосолов С.Н. Сравнительная эффективность профилактического применения карбоната лития, карбамазепина, вальпроата натрия при аффективных и шизоаффективных психозах. Журнал неврологии и психиатрии им. С.С. Корсакова. 1991;4:78-83 [Mosolov S. Comparative efficacy of preventive use of lithium carbonate, carbamazepine and sodium valproate in affective and schizoaffective psychoses. S.S. Korsakov Journal of Neurology and Psychiatry. 1991;4:78-83 (in Russian)].
- Костюкова Е.Г., Мосолов С.Н. Соли лития и антиконвульсанты при профилактической терапии рецидивов биполярного аффективного расстройства. Современная терапия психических расстройств. 2012;4:2-10 [Kostyukova EG, Mosolov SN. Lithium and anticonvulsants for prevention of recurrence in bipolar affective disorder. Current Therapy of Mental Disorders. 2012;4:2-10 (in Russian)].
- Bowden CL, Mosolov S, Hranov L, et al. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial. Int Clin Psychopharmacol. 2010;25:60-7. doi: 10.1097/YIC.0b013e328333ac1b
- Мосолов С.Н., Рывкин П.В., Сердитов О.В., и др. Метаболические побочные эффекты современной антипсихотической фармакотерапии. Социальная и клиническая психиатрия. 2008;18(3):75-90 [Mosolov SN, Ryvkin, MY, Serditov OV, et al. Metabolic side effects of the current antipsychotic pharmacotherapy. Social and Clinical Psychiatry. 2008;18(3):75-90 (in Russian)].
- Keck PE, Orsulak PJ, Cutler AJ, et al. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord. 2009;112:36-49. doi: 10.1016/j.jad.2008.05.014
- Ahrens B, Grof P, Moller HJ, et al. Extended survival of patients on long-term lithium treatment. Can J Psychiat. 1995;40:241-6. doi: 10.1177/070674379504000504
- Алфимов П.В., Рывкин П.В., Ладыженский М.Я., и др. Метаболический синдром у больных шизофренией (обзор литературы). Современная терапия психических расстройств. 2014;3:8-14 [Alfimov PV, Ryvkin PV, Ladyzhensky MY, et al. Metabolic syndrome in patients with schizophrenia (a review). Current Therapy of Mental Disorders. 2014;3:8-14 (in Russian)].
- Li C, Birmaher B, Rooks B, et al. High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder. J Clin Psychiatry. 2019;30;80(4):18m12422. doi: 10.4088/JCP.18m12422
- Chen J, Chen H, Feng J, et al. Association between hyperuricemia and metabolic syndrome in patients suffering from bipolar disorder. BMC Psychiatry. 2018;18:390. doi: 10.1186/s12888-018-1952-z
- Мосолов С.Н., Малин Д.И., Рывкин П.В., и др. Лекарственные взаимодействия препаратов, применяемых в психиатрической практике. Современная терапия психических расстройств. 2019;S1:2-35 [Mosolov SN, Malin DI, Ryvkin PV, et al. Psychotropic Drugs Interaction. Current Therapy of Mental Disorders. 2019;S1:2-35 (in Russian)]. doi: 10.21265/PSYPH.2019.50.40828